Deep Tech Startups

Percepio develops Tracealyzer, a software tool for tracing and visual analysis of embedded systems and software. The company serves embedded systems developers and the embedded software industry.

1 investor

Percepta applies AI research to solve problems in legacy industries. The company focuses on bridging research with practical applications for critical institutions.

1 investor

Perceptive Sensor Technologies develops non-intrusive acoustic identification and monitoring systems that use ultrasonic technology to identify liquid contents in sealed containers and monitor fluid conditions in real time. The technology serves defense, petrochemical, pharmaceutical, food and beverage, mining, and logistics sectors for applications including product verification, contamination detection, and inventory management.

1 investor

Peregrine.ai develops computer vision and machine learning systems for the mobility sector, helping fleet operators and vehicle manufacturers reduce accidents, emissions, and infrastructure barriers through intelligent analysis of camera sensor data.

1 investor

PERFI develops a volumetric 3D printing technology that uses patented light projection to solidify a light-sensitive polymer inside a rotating cylinder, forming entire objects at once rather than layer-by-layer. It offers printing modules, encapsulated material capsules, and one-click software aimed at business owners without prior additive manufacturing experience for personalized, on-demand production.

1 investor

Perfobore develops drilling and stimulation technology for oil and gas wells. The company applies scientific innovations to improve well development processes while maintaining environmental compliance standards.

1 investor

PerFormS is an innovative startup spun out of the Department of Life Sciences at the University of Modena and Reggio Emilia that develops health products using advanced formulation and nanotechnology to improve the bioavailability of active molecules. Its first patented technology targets an endogenous anti-inflammatory molecule for patients with acute or chronic skin inflammation such as psoriasis, positioned as an alternative to cortisone.

1 investor

Perimeter designs and engineers people-sensing systems that detect human presence in real time at the edge, covering indoor, outdoor, above-ground, and below-ground environments. Its anonymous sensors use edge AI to detect people without cameras, audio, or identity data, aimed at high-security environments and perimeter monitoring.

1 investor

Perimeter Institute for Theoretical Physics is an independent research institute devoted to foundational theoretical physics research at the international level. The institute conducts research, provides graduate training, and operates educational outreach programs for the public in Canada and beyond.

1 investor

P-Scope manufactures a disposable minimally invasive scope for direct abdominal cavity visualization under local anesthesia, designed for gastroenterology, oncology, gynecology, and critical care applications. The device eliminates the need for general anesthesia and inpatient surgery for diagnostic abdominal examination.

1 investor

Perlara is a biotech company that runs early-stage drug R&D programs for rare diseases, partnering with patient families, companies and impact investors to screen gene-edited patient avatars for repurposable drugs. It has launched drug repurposing trials at Mayo Clinic for rare conditions such as PMM2-CDG and NGLY1-CDDG.

1 investor

GigaCrop develops agricultural biotechnology to improve photosynthesis in crop plants through enzyme engineering, enabling more sustainable and efficient food and materials production. The company focuses initially on major crops like corn and soybean, with plans to expand to plants for biomanufacturing.

1 investor

PERME is a deep-tech home-testing platform that converts biological samples into digital health information in real time using an affordable device that does not require a lab, then applies data analytics and AI/ML to generate personalized health recommendations and telehealth consultations. Operating a B2B2C model, it serves individuals and partners with corporations for anonymized user-data analytics in the healthcare and wellness sectors, with labs in the United States and Israel.

1 investor

Permeasis Therapeutics is developing a Membrane Translocation Domain (MTD) platform that enables intracellular delivery of proteins and other large therapeutic macromolecules to the cytosol and intracellular compartments. The company initially targets genetically defined diseases where delivering functional proteins inside cells could have therapeutic impact.

1 investor

Perseo Pharma is a biotech spin-off from the University of Applied Sciences in Basel, Switzerland, developing enzyme immobilization and bioconjugation technologies for therapeutic applications. The company focuses on creating novel platforms for drug delivery and enzyme-based therapies targeting inborn errors of metabolism and other rare diseases.

1 investor

Perseus SENOLYTIX is a gerotherapeutics company developing senolytic peptides to target senescent cells and restore cellular balance in aging organisms. The company focuses on translating scientific discoveries into therapeutics addressing fundamental mechanisms of aging.

1 investor

Parsian Tarava manufactures needle-style reusable electrodes for electroporation applications in gene transfer and drug delivery across in vivo, ex vivo, and in ovo conditions. The electrodes are designed for use in research, biomedical, genetic, and pharmaceutical settings.

1 investor

Petal Surgical develops an incisionless surgery platform using Millisecond Pulse Histotripsy, a form of focused therapeutic ultrasound that breaks down targeted tissue via "Acoustic Liquefaction" without cutting, heat, or trauma. The technology is designed for patients, clinicians, and hospitals as a less invasive alternative to traditional surgery.

1 investor

PETAL Solutions provides turbine technology consulting and aerothermal expertise, leveraging advanced computational fluid dynamics and engine modeling capabilities. The company serves aerospace, power generation, and turbomachinery clients requiring research, design optimization, and technical consulting.

1 investor

Petrabytes provides drone data platform services, offering geospatial intelligence and data analysis capabilities across energy, healthcare, and transportation sectors.

1 investor

A research lab building AI models trained to decode physical-world signals from instruments and to operate those instruments, using real-world measurement as the training signal rather than text corpora. It positions itself in machine learning and deeptech applied to physical sensing.

1 investor

PexMachina develops physics-based molecular simulation for drug discovery, using quantum-ready computational chemistry and AI agents to predict properties like binding, stability, and oral availability of peptides. It delivers its PexAgent as an MCP service that integrates into LLM platforms such as Claude and Gemini, letting pharmaceutical researchers run molecular simulations via natural language within existing R&D workflows.

1 investor

Peytant develops amnion-derived membrane coverings using human placental tissue to reduce the body's foreign body response in implants used for luminal disease treatment. The company's products are designed to increase patency and help clinicians manage vascular and other luminal conditions.

1 investor

Pfenex provides a Pseudomonas fluorescens-based microbial expression platform for manufacturing recombinant proteins, antibodies, and biologics at scale. The platform supports development from construct to production strain and enables technology transfer to CDMOs and manufacturing partners.

1 investor